Morning Medical with Dr. Chow
A daily update covering the latest medical & health news from around the world using artificial intelligence. Doctor Chi-Ming Chow is a family physician, general internist, and cardiologist. He is also a Professor of Medicine at the University of Toronto.
Pemvidutide Shows Promise for Reducing Heavy Drinking
Could an investigational GLP-1 drug help treat alcohol use disorder? Dr. Chi-Ming Chow reviews a 100-patient phase 2 trial in which pemvidutide reduced heavy drinking days over 24 weeks. He also examines toilet posture, hospital wastewater as a potential hotspot for antibiotic-resistant bacteria, and calls to improve endometriosis care in Quebec.
Key Points
- Squatting may help some people have quicker, easier bowel movements than sitting, though comfort and safety should guide what works best for each person.
- An investigational GLP 1 drug, pemvidutide, showed early promise for reducing heavy drinking days in alcohol use disorder and may also improve weight and liver markers.
- Hospital wastewater may help drive antibiotic resistance, while endometriosis care gaps in Quebec and rising grocery costs in Windsor Essex highlight how health is shaped by system level access and affordability.
Chapters
| 0:00 | |
| 2:08 | |
| 8:44 |
Transcript
Loading transcript...
- / -